100 Kidney Failure Facts

Understanding Kidney Failure (Facts 1-15)

  1. Kidney failure occurs when the kidneys lose the ability to filter waste and excess water from the blood.
  2. Kidney failure is also called renal failure or end-stage renal disease (ESRD).
  3. There are two main types of kidney failure: acute kidney injury (AKI) and chronic kidney disease (CKD).
  4. Acute kidney injury is sudden loss of kidney function over hours to days.
  5. Chronic kidney disease develops gradually over months to years.
  6. Stage 5 chronic kidney disease (GFR <15 mL/min/1.73m²) is the medical definition of kidney failure.
  7. At Stage 5 CKD, kidneys function at less than 10-15% of normal capacity.
  8. Kidney failure is a serious, life-threatening condition requiring treatment.
  9. Untreated kidney failure leads to accumulation of toxic wastes and electrolyte imbalances.
  10. Kidney failure can develop from many different underlying causes.
  11. The progression from healthy kidneys to kidney failure varies greatly among individuals.
  12. Some people progress to kidney failure over years; others over months.
  13. Early detection and treatment can slow or sometimes halt kidney failure progression.
  14. Kidney failure is increasingly common, affecting millions of people worldwide.
  15. Kidney failure rates have increased significantly over the past two decades.

Causes of Acute Kidney Injury (Facts 16-35)

  1. Acute kidney injury (AKI) is sudden deterioration in kidney function.
  2. AKI can develop over hours to days.
  3. AKI may be reversible if the underlying cause is addressed quickly.
  4. Pre-renal AKI results from decreased blood flow to the kidneys.
  5. Severe dehydration can cause pre-renal AKI.
  6. Severe bleeding or blood loss leads to pre-renal AKI.
  7. Sepsis and severe infection cause pre-renal AKI through hemodynamic changes.
  8. Heart failure reduces cardiac output and blood flow to kidneys, causing AKI.
  9. Intrinsic renal AKI involves direct damage to kidney tissue.
  10. Acute tubular necrosis (ATN) is the most common form of intrinsic AKI.
  11. Medications including aminoglycosides and NSAIDs cause drug-induced AKI.
  12. Contrast dye used in imaging procedures can cause contrast-induced AKI.
  13. Myoglobin released from muscle damage (rhabdomyolysis) causes AKI.
  14. Hemoglobin from severe hemolysis can cause AKI.
  15. Sepsis from serious bacterial infection damages kidney tissue directly.
  16. Post-renal AKI results from obstruction of urine flow.
  17. Kidney stones can obstruct the ureter and cause AKI.
  18. Enlarged prostate obstructs urine flow and causes AKI.
  19. Tumors can obstruct the urinary tract and cause AKI.
  20. Severe dehydration combined with NSAIDs significantly increases AKI risk.

Causes of Chronic Kidney Disease Progression (Facts 36-60)

  1. Diabetes is the leading cause of kidney failure worldwide.
  2. Type 1 diabetes causes diabetic nephropathy through high blood glucose.
  3. Type 2 diabetes causes diabetic nephropathy through metabolic changes.
  4. Diabetic kidney disease typically develops 10-20 years after diabetes onset.
  5. High blood pressure is the second leading cause of kidney failure.
  6. Hypertension damages kidney blood vessels, reducing filtration capacity.
  7. Glomerulonephritis (inflammation of glomeruli) can lead to kidney failure.
  8. IgA nephropathy is the most common primary glomerulonephritis worldwide.
  9. Lupus nephritis causes kidney failure in systemic lupus erythematosus.
  10. Vasculitis damages kidney blood vessels and causes kidney failure.
  11. Polycystic kidney disease causes progressive kidney failure with cyst development.
  12. Obstructive nephropathy from kidney stones or tumors causes progressive damage.
  13. Reflux nephropathy from urine backflow damages the kidneys over time.
  14. Chronic pyelonephritis (recurrent kidney infections) can cause kidney failure.
  15. HIV infection increases glomerulonephritis and kidney disease risk.
  16. Hepatitis C increases kidney disease and glomerulonephritis risk.
  17. Drug-induced kidney disease from chronic medication use causes CKD.
  18. Contrast dye from repeated imaging procedures accumulates and damages kidneys.
  19. Chronic NSAID use damages the kidneys over time.
  20. Lithium used for bipolar disorder can cause chronic kidney disease.
  21. Herbal remedies containing aristolochic acid cause severe kidney damage.
  22. Cocaine and amphetamines damage kidney blood vessels.
  23. Chronic drug and alcohol use increases kidney disease risk.
  24. Recurrent dehydration episodes accelerate CKD progression.
  25. Multiple risk factors accelerate kidney disease progression significantly.

Complications of Kidney Failure (Facts 61-90)

  1. Anemia develops because kidneys stop producing erythropoietin (EPO).
  2. Anemia in kidney failure causes fatigue and weakness.
  3. Severe anemia increases cardiovascular disease risk in kidney failure.
  4. Hyperkalemia (high potassium) is life-threatening and causes cardiac arrhythmias.
  5. Potassium-rich foods must be restricted in kidney failure.
  6. Cardiac arrhythmias from high potassium can cause sudden cardiac death.
  7. Hypertension worsens with kidney failure due to fluid and sodium retention.
  8. Fluid overload in kidney failure leads to pulmonary edema (water in lungs).
  9. Shortness of breath from pulmonary edema is a medical emergency.
  10. Congestive heart failure develops or worsens with kidney failure.
  11. Hyperphosphatemia (high phosphorus) causes secondary hyperparathyroidism.
  12. Secondary hyperparathyroidism causes renal osteodystrophy (bone disease).
  13. Bone disease in kidney failure increases fracture risk.
  14. Soft tissue and vascular calcification occurs with phosphate accumulation.
  15. Uremic pericarditis (inflammation of heart sac) can occur in severe kidney failure.
  16. Uremia causes encephalopathy with confusion, irritability, and altered mental status.
  17. Uremic syndrome includes nausea, vomiting, itching, and poor appetite.
  18. Uremic toxins accumulate in untreated kidney failure.
  19. Gastrointestinal bleeding occurs more frequently in kidney failure.
  20. Immune dysfunction in kidney failure increases infection risk.
  21. Malnutrition develops due to poor appetite and dietary restrictions.
  22. Muscle wasting (sarcopenia) occurs with malnutrition in kidney failure.
  23. Depression and anxiety are common psychological complications of kidney failure.
  24. Sexual dysfunction and infertility occur in kidney failure.
  25. Peripheral neuropathy (nerve damage) develops with chronic uremia.
  26. Restless leg syndrome affects sleep in kidney failure.
  27. Insomnia and sleep disorders are common in kidney failure.
  28. Cognitive impairment can develop in chronic kidney failure.
  29. Bleeding tendency increases due to platelet dysfunction in kidney failure.
  30. Susceptibility to infection increases significantly in kidney failure patients.

Symptoms and Signs of Kidney Failure (Facts 91-110)

  1. Many early signs of kidney failure are nonspecific and easily overlooked.
  2. Fatigue and weakness are often the first symptoms of kidney failure.
  3. Nausea and loss of appetite are common early signs.
  4. Swelling (edema) in legs, ankles, and face occurs with fluid retention.
  5. Shortness of breath may indicate fluid overload or anemia.
  6. High blood pressure may develop or worsen with kidney failure.
  7. Back or side pain may occur from underlying kidney disease.
  8. Changes in urination patterns (frequency, volume, color) signal kidney failure.
  9. Foamy or bubbly urine indicates protein loss from kidney failure.
  10. Itching (pruritus) is a common and bothersome symptom of kidney failure.

Diagnosis of Kidney Failure (Facts 101-125)

  1. Serum creatinine level is the primary marker used to assess kidney failure.
  2. Estimated GFR (eGFR) is calculated from creatinine and used to stage kidney disease.
  3. A GFR below 15 mL/min/1.73m² defines Stage 5 kidney failure.
  4. Urine albumin-to-creatinine ratio (UACR) detects early kidney damage.
  5. Urinalysis shows proteinuria and may show blood or casts.
  6. Complete blood count (CBC) detects anemia associated with kidney failure.
  7. Comprehensive metabolic panel (CMP) shows electrolyte abnormalities.
  8. Hyperkalemia (high potassium) is dangerous and requires immediate treatment.
  9. Hyperphosphatemia (high phosphorus) is common in kidney failure.
  10. Hypocalcemia (low calcium) develops due to impaired vitamin D activation.
  11. Blood urea nitrogen (BUN) is elevated in kidney failure.
  12. BUN-to-creatinine ratio helps differentiate types of kidney failure.
  13. Parathyroid hormone (PTH) is elevated in secondary hyperparathyroidism.
  14. Intact PTH (iPTH) is monitored to assess bone disease in kidney failure.
  15. Alkaline phosphatase may be elevated with bone disease.
  16. Albumin and prealbumin levels indicate nutritional status.
  17. Lipid panel often shows abnormal cholesterol in kidney failure.
  18. Renal ultrasound shows kidney size and architecture.
  19. Small kidneys (usually <9 cm) indicate advanced chronic kidney disease.
  20. Bilateral small kidneys confirm chronic rather than acute kidney failure.
  21. Kidney biopsy may be performed to diagnose underlying kidney disease.
  22. Renal artery stenosis screening may be done if suspicion is high.
  23. Blood pressure monitoring is part of kidney failure assessment.
  24. Dipstick urinalysis is a simple screening test for proteinuria.
  25. Urine microscopy identifies casts, cells, and crystals.

Medical Management of Kidney Failure (Facts 126-160)

  1. ACE inhibitors reduce proteinuria and slow kidney failure progression.
  2. Angiotensin receptor blockers (ARBs) provide similar kidney protection to ACEi.
  3. SGLT2 inhibitors recently shown to slow CKD progression in diabetic patients.
  4. GLP-1 receptor agonists reduce kidney disease progression in diabetes.
  5. Finerenone is a non-steroidal mineralocorticoid receptor antagonist for CKD.
  6. Blood pressure control slows kidney failure progression.
  7. Target blood pressure in CKD is typically <130/80 mmHg.
  8. Diuretics help manage fluid overload and hypertension.
  9. Loop diuretics are often needed in advanced kidney failure.
  10. Sodium restriction limits fluid retention and hypertension.
  11. Target sodium intake is less than 2,300 mg daily in kidney failure.
  12. Phosphate binders reduce phosphorus absorption in the GI tract.
  13. Calcium acetate binds phosphate but increases calcium absorption.
  14. Sevelamer (non-calcium binder) controls phosphate without calcium.
  15. Lanthanum carbonate effectively binds phosphate in kidney failure.
  16. Vitamin D supplementation corrects deficiency and supports bone health.
  17. Calcimetics like cinacalcet reduce PTH in secondary hyperparathyroidism.
  18. Erythropoietin-stimulating agents (ESAs) treat anemia in kidney failure.
  19. Iron supplementation is essential with ESA use.
  20. Statin medications reduce cardiovascular disease risk in kidney failure.
  21. Aspirin may be used for cardiovascular protection in select patients.
  22. Beta-blockers provide blood pressure control and cardiac protection.
  23. Calcium channel blockers offer blood pressure control with renal protection.
  24. Anticoagulation may be needed for atrial fibrillation in kidney failure.
  25. Immunosuppression treats autoimmune causes of kidney failure.

Dialysis Preparation and Planning (Facts 161-185)

  1. Patients should ideally start planning dialysis 6-12 months before needing it.
  2. Vascular access creation requires time to mature before use.
  3. Arteriovenous (AV) fistula creation requires 2-3 months to mature.
  4. AV graft maturation takes 2-4 weeks.
  5. Peritoneal dialysis catheter placement requires 1-2 weeks to heal.
  6. Catheter placement timing affects ability to use dialysis immediately.
  7. Unplanned dialysis starts are associated with worse outcomes.
  8. Dialysis education should begin well before kidney failure stage 5.
  9. Patients should understand dialysis options (hemodialysis vs. peritoneal).
  10. Vascular access decisions affect long-term dialysis outcomes.
  11. Fistula first, graft second, catheter last is the recommended access strategy.
  12. Arteriovenous fistula has best long-term outcomes of vascular accesses.
  13. Graft infection rates exceed fistula infection rates.
  14. Catheter-related bloodstream infections are common complications.
  15. Temporary catheters should not be used long-term due to infection risk.
  16. Pre-dialysis counseling improves patient knowledge and preparation.
  17. Nutritional counseling should begin in Stage 4 CKD.
  18. Medication review ensures appropriate dosing for kidney failure.
  19. Home modifications may be needed for peritoneal dialysis.
  20. Transportation arrangements are necessary for hemodialysis patients.
  21. Work and lifestyle adjustments must be planned before dialysis starts.
  22. Financial counseling helps navigate costs and insurance.
  23. Mental health support should be offered during dialysis transition.
  24. Support groups provide peer support during dialysis preparation.
  25. Advance care planning is important before dialysis initiation.

Hemodialysis (Facts 186-210)

  1. Hemodialysis is treatment that removes waste and water using a machine.
  2. Standard hemodialysis requires three 4-hour sessions per week.
  3. Hemodialysis can remove 1-2 pounds of excess fluid per treatment.
  4. Treatment schedules can be modified based on residual kidney function.
  5. Twice-weekly dialysis may be adequate for patients with significant residual function.
  6. Nocturnal hemodialysis involves 5-6 nights per week for better clearance.
  7. Short, frequent hemodialysis improves solute clearance and outcomes.
  8. Kt/V and URR measure dialysis adequacy.
  9. Kt/V should be at least 1.2 for adequate hemodialysis.
  10. Residual kidney function declines over time on hemodialysis.
  11. Preserving residual function improves outcomes and quality of life.
  12. Intradialytic weight gain should not exceed 2-3 kg between sessions.
  13. Hypotension during hemodialysis causes dizziness and syncope.
  14. Dialysis disequilibrium syndrome occurs with first treatments.
  15. Vascular steal syndrome causes hand pain and coolness.
  16. Carpal tunnel syndrome develops from dialysate leakage in some cases.
  17. Blood clotting in vascular access causes loss of function.
  18. Aneurysms can develop in long-standing arteriovenous fistulas.
  19. Access thrombosis requires intervention or access replacement.
  20. Anticoagulation (usually heparin) is used during hemodialysis.
  21. Warfarin is used between treatments if anticoagulation is needed.
  22. Heparin-free dialysis is an option for patients with heparin allergy.
  23. Dialysis membranes vary in biocompatibility and clearance ability.
  24. High-flux membranes improve clearance of larger molecules.
  25. Bicarbonate dialysate is standard, replacing older acetate dialysate.

Peritoneal Dialysis (Facts 211-235)

  1. Peritoneal dialysis uses the peritoneal membrane as a natural filter.
  2. Continuous ambulatory peritoneal dialysis (CAPD) involves multiple daily exchanges.
  3. Automated peritoneal dialysis (APD) uses a cycler machine overnight.
  4. Peritoneal dialysis allows more flexibility and independence than hemodialysis.
  5. Peritoneal dialysis catheter placement requires surgical or interventional placement.
  6. Peritoneal dialysate is infused into the abdomen where exchange occurs.
  7. Dwell time refers to how long dialysate remains in the abdomen.
  8. Longer dwell times allow better solute clearance in CAPD.
  9. Exchange frequency must be adequate to remove waste products.
  10. Peritoneal equilibration test (PET) determines individual transport characteristics.
  11. Fast transporters may need different dialysate prescriptions.
  12. Peritonitis (peritoneal cavity infection) is the major complication of peritoneal dialysis.
  13. Peritonitis symptoms include abdominal pain, cloudiness in dialysate, and fever.
  14. Peritonitis requires immediate antibiotic therapy, often empiric initially.
  15. Repeated peritonitis can cause peritoneal membrane failure.
  16. Catheter exit site infections must be treated promptly.
  17. Tunnel infections around the catheter may require catheter replacement.
  18. Dialysate leakage can occur and affect treatment efficacy.
  19. Abdominal wall hernias develop in some peritoneal dialysis patients.
  20. Encapsulating peritoneal sclerosis can develop after years on peritoneal dialysis.
  21. Sclerosing encapsulating peritonitis is rare but serious.
  22. Dietary restrictions in peritoneal dialysis are less strict than hemodialysis.
  23. Peritoneal dialysis patients have fewer dietary sodium restrictions.
  24. Protein losses in peritoneal dialysate are greater than hemodialysis.
  25. Increased protein intake is recommended for peritoneal dialysis patients.

Prognosis and Life Expectancy (Facts 236-250)

  1. Life expectancy on dialysis has improved significantly over recent decades.
  2. Average life expectancy for dialysis patients is 5-10 years.
  3. Younger dialysis patients have better long-term survival than elderly patients.
  4. Dialysis can extend life for 10-20+ years in some patients.
  5. The first year on dialysis is critical, with highest mortality risk.
  6. Cardiovascular disease is the leading cause of death in dialysis patients.
  7. Infection is the second leading cause of death in dialysis patients.
  8. Sudden cardiac death occurs in some dialysis patients.
  9. Mortality risk increases with age, comorbidities, and poor adherence.
  10. Hospitalization frequency increases with poor dialysis outcomes.
  11. Quality of life depends on dialysis prescription and overall health.
  12. Rehabilitation and exercise improve outcomes in dialysis patients.
  13. Medication adherence improves survival in dialysis patients.
  14. Dietary adherence improves lab values and outcomes.
  15. Early transplantation provides superior outcomes compared to prolonged dialysis.

Click here to add text.